One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Pancreatic cancer: a state of emergency?
doi : 10.1016/S2468-1253(20)30397-6
Volume 6, Issue 2, February 2021, Page 81
Moving forward with organ preservation in rectal cancer
Geerard LBeetsab
Chronic hepatitis B: identifying who needs to be treated and improving linkage to care
Is dilution the solution in gastric cancer?
MautinHundeyinaVivian EStronga
Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B
Won-MookChoiaJonggiChoiaGrace Lai-HungWongbSeungbongHancYoung-SukLima
Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B – Authors' reply
Cheng-HaoTsengabcYao-ChunHsuabcMindie HNguyend
From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative
Ajay MVermaa†AnushaPatelaSreedharSubramanianb†Philip JSmithbâ€
Identifying the lower age limit for hepatitis C screening in large elimination programmes in highly endemic areas
SaeedHamidaAdeelAbidaGregory JDoreb
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study
Simon PBachFRCSacAlexandraGilbertFRCReKristianBrockPhDaStephanKorsgenFRCScIanGehFRCRdProfJamesHillFRCSfTalvinderGillFRCSgPaulHainsworthFRCShMatthew GTuttonFRCSiJimKhanFRCSjJonathanRobinsonFRCSkMarkStewardFRCSkChristopherCunninghamFRCSlBruceLevyFRCSmAlanBeveridgeFRCSnKellyHandleyPhDbManjinderKaurBScbNatalieMarchevskyMScb…TijaniUmar
Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis
MingjuanTanMDac†Ajeet SBhadoriaMDb†FuqiangCuiPhDaAlexTandJudithVan HoltenPhDaPhilippaEasterbrookMDaNathanFordFRCPEaQinHanMDaYingLuPhDaMarcBulterysMDaYvanHutinMDa
Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial
ProfHan KwangYangMDaProfJiafuJiMDbProfSang UkHanMDcMasanoriTerashimaMDdProfGuoxinLiMDeProfHyung HoKimMDfProfSimonLawMDgAsimShabbirFRCShProfKyo YoungSongMDiProfWoo JinHyungMDjNik RitzaKosaiFRCSkProfKojiKonoMDlKazunariMisawaMDmHiroshiYabusakiMDnTakahiroKinoshitaMDoPeng ChoongLauMDpProfYoung WooKimMDqJaideep RajRaoFRCSr…Jimmy B.Y.So
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
ProfVolkerKunzmannMDaProfJens TSivekeMDcProfHanaAlgülMDdErayGoekkurtMDfGabrieleSieglerMDgProfUweMartensMDiDirkWaldschmidtMDjUwePelzerMDkMartinFuchsMDmProfFrankKullmannMDnProfStefanBoeckMDoThomas JEttrichMDpSwantjeHeldMScqRalphKellerMEdrProfIngoKleinMDbProfChristoph-ThomasGermerMDbProfHubertSteinMDhProfHelmutFriessMDe…WolfgangBlau
The overlap between irritable bowel syndrome and organic gastrointestinal diseases
ImranAzizMDa†ProfMagnusSimrénMDbcâ€
